Any topic (writer’s choice)

https://www.hsph.harvard.edu/news/magazine/winter10assessment/

The following prompt is based on an interview about cost effectiveness research with Professor Weinstein from the Harvard School of Public Health.

Why are some expensive treatments (like lung transplants and pap smears) considered to be bad value and other expensive treatments (like aromatese inhibitors, an expensive class of drugs to treat breast cancer) to be good value?
What can the U.S. do to address the problem of overusing medical care that is not cost effective, and why isnt the U.S. doing this already?

You can place an order similar to this with us. You are assured of an authentic custom paper delivered within the given deadline besides our 24/7 customer support all through.